Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.

Minister for Information Technology, Biotechnology and Rural Development Priyank Kharge said the state will unveil an Ocean Farming Policy, back AI–biotech convergence, and push a greener data ...

The Director-General /Chief Executive Officer of the National Biosafety Management Agency (NBMA), Mr. Bello Bawa Bwari has ...

By Liz McLaughlin, WRAL climate change reporter Inside a lab at North Carolina State University, large metal tanks hum as microorganisms grow inside a carefully controlled environment. It looks a bit ...

Pandorum’s primary focus is on ocular surface diseases, such as Stevens–Johnson Syndrome and Neurotrophic Keratitis, for ...

The diversity of the state’s emerging and mature medical technology firms offers some economic insulation from a blend of factors, global and local, that point to challenges down the road.

Though transhumanism presents ground-breaking advancements, it challenges ethical and societal values. The integration of ...

Australian research could be key to combating the rising threat of antibiotic resistance and saving millions of lives.

In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves ...

Eli Lilly to acquire Orna Therapeutics for up to $2.4B, boosting in vivo CAR-T and circular RNA therapies for autoimmune disease.